BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 166481)

  • 21. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK; Krishnakantha TP
    Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Turnover of hepatic catalase modified by aminotriazole.
    Nakamura A; Minakami S
    J Biochem; 1973 Oct; 74(4):683-9. PubMed ID: 4763658
    [No Abstract]   [Full Text] [Related]  

  • 23. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphometric and cytochemical evaluation of clofibrate-induced peroxisomal proliferation in adult rat hepatocytes cultured on floating collagen gels.
    Furukawa K; Mochizuki Y; Sawada N; Gotoh M; Tsukada H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(5):279-85. PubMed ID: 2901167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisomal beta-oxidation and catalase activities in fetal rat liver: effect of maternal treatment with clofibrate.
    Cibelli A; Stefanini S; Ceru MP
    Cell Mol Biol; 1988; 34(2):191-205. PubMed ID: 3378247
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of chronic ethanol, catalase inhibitor 3-amino-1,2,4-triazole and clofibrate treatment on lipid peroxidation in rat myocardium.
    Antonenkov VD; Pirozhkov SV; Popova SV; Panchenko LF
    Int J Biochem; 1989; 21(12):1313-8. PubMed ID: 2612724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
    Leighton F; Coloma L; Koenig C
    J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clofibrate increases the number of peroxisomes and of lamellar bodies in alveolar cells type II of the rat lung.
    Fringes B; Gorgas K; Reith A
    Eur J Cell Biol; 1988 Apr; 46(1):136-43. PubMed ID: 3260863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on peroxisomes. V. Effect of ethyl p-chlorophenoxyisobutyrate on the centrifugal behavior of rat liver peroxisomes.
    Hayashi H; Suga T; Ninobe S
    J Biochem; 1975 Jun; 77(6):1199-204. PubMed ID: 5399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of xanthine dehydrogenase in rat liver in response to peroxisome proliferators.
    Satoh A; Sasago S; Takahashi S; Kato N
    Biochem Biophys Res Commun; 1993 Sep; 195(2):751-7. PubMed ID: 8373410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The peroxisome proliferation-associated polypeptide in rat liver.
    Reddy JK; Kumar NS
    Biochem Biophys Res Commun; 1977 Aug; 77(3):824-9. PubMed ID: 901515
    [No Abstract]   [Full Text] [Related]  

  • 32. Microbodies in experimentally altered cells. IX. The fate of microbodies.
    Svoboda D; Reddy J
    Am J Pathol; 1972 Jun; 67(3):541-54. PubMed ID: 4338207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactive potential of omega-3 fatty acids with clofibrate or DEHP on hepatic peroxisome proliferation in male Wistar rats.
    Wysynski AM; Baldwin LA; Leonard DA; Calabrese EJ
    Hum Exp Toxicol; 1993 Jul; 12(4):337-40. PubMed ID: 8104013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cetaben versus clofibrate: comparison of toxicity and peroxisome proliferation in rats.
    Fort FL; Stein HH; Langenberg K; Lewkowski JP; Heyman IA; Kesterson JW
    Toxicology; 1983 Nov; 28(4):305-11. PubMed ID: 6606240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in peroxisomes in preneoplastic liver of rats induced by 3'-methyl-4-dimethylaminoazobenzene.
    Itabashi M; Mochizuki Y; Tsukada H
    Cancer Res; 1977 Apr; 37(4):1-35-43. PubMed ID: 191174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.
    Reddy JK
    J Histochem Cytochem; 1973 Nov; 21(11):967-71. PubMed ID: 4587529
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxicological studies on a benzofurane derivative. II. Demonstration of peroxisome proliferation in rat liver.
    Butler EG; Ichida T; Maruyama H; Schulte-Hermann R; Williams GM
    Toxicol Appl Pharmacol; 1990 Dec; 106(3):500-8. PubMed ID: 2260096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increases in tissue levels of ubiquinone in association with peroxisome proliferation.
    Aberg F; Zhang Y; Teclebrhan H; Appelkvist EL; Dallner G
    Chem Biol Interact; 1996 Jan; 99(1-3):205-18. PubMed ID: 8620569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-influenced CPIB-induction of peroxisomes in rat liver and kidney tissues.
    Henry EW; DeMorrow JM
    Cytobios; 1985; 42(169S):279-93. PubMed ID: 4028834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular distribution of hepatic catalase activity in rats treated with aminotriazole and allylisopropylacetamide.
    Nakamura A; Hara T; Minakami S
    J Biochem; 1973 Jan; 73(1):47-53. PubMed ID: 4690233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.